•Assess both monotherapy and combination regimens that have demonstrated efficacy in advanced and metastatic gastric and gastroesophageal junction cancers across all lines of therapy
•Review medical society guidelines for the treatment of advanced gastric cancer and gastroesophageal junction cancer from first-line through subsequent lines of treatment.
•Describe the development of treatment strategies and the management of adverse events to optimize efficacy and quality of life in the care of patients with advanced GC and GEJ
Wednesday, October 24, 2018 at 12:00pm to 1:00pm
Fred and Pamela Buffett Cancer Center, 5.12.331 505 S 45th St, Omaha, NE 68106